SEC EDGAR CompanyFacts fact · reporting period
ADIAL PHARMACEUTICALS, INC.: net_income
One fact, its scope and the complete path back to the official record.
Reported value
$-5.123T{"amount": -5123341000000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}- Metric
- net_income
- Period
- 2023-01-01 – 2023-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-28T12:49:40.927146+02:00
Raw response SHA-256
fe1f8c053e07a6f20e5f7b99fc60e9be…Official-identifier path
https://factanker.com/fact/sec/cik-0001513525/net-income/2023-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": -5123341, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001213900-24-028701)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.